IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
Content includes: - Market Data - Interviews and Analysis - Special Features (Market Forecasts, M&A Analysis, Executive Compensation Table, Surveys, etc.) - Company Financial Results - Product Developments - Regional and Industry Opportunities
Page Count: 50
Table of Contents
IBO Company of the Year: Biotage
Molecular Cancer Diagnostics: NGS to Overtake PCR in Market Share by 2025
Executive Briefing
Illumina Hits MGI with Two Injunction Motions and New Suit
New Bioprocessing Firm Adds Chromatography and Bioreactor Lines
MS Supplier and LC Vendor Join Forces
Fluidigm Makes Sample Prep Acquisition
Malvern Panalytical Sells Rheometry Portfolio
Genovis Captures Antibody Firm
Nanalysis Diversifies
Pipette Calibration Firm Acquired
IBO Stock Indexes Suffer as Coronavirus Outbreak Impacts the Global Economy
What is the Size of IVD Market Segments? Who’s Winning? Who’s Merged? Who’s Launched Game-Changing Products?
One book definitively answers these questions, from a publisher that is focused on in vitro diagnostics. Now in its 13th edition, this…